Clinical Pharmacology and Drug Toxicity Practice Questions

Q: Which of the following statements about methyl alcohol poisoning is incorrect?

Fomepizole competitively inhibits aldehyde dehydrogenase. ***Fomepizole competitively inhibits aldehyde dehydrogenase*** - **Fomepizole** acts as a competitive inhibitor of **alcohol dehydrogenase**, not aldehyde dehydrogenase. - By inhibiting alcohol dehydrogenase, fomepizole prevents the metabolism of methanol into toxic metabolites like formic acid. *Effects are due to formic acid* - This statement is correct. The primary toxicity of methanol poisoning is due to its metabolism into **formic acid** by alcohol and aldehyde dehydrogenases. - Formic acid is responsible for the **metabolic acidosis** and **ocular toxicity** observed. *Metabolic acidosis* - This statement is correct. Methanol poisoning leads to severe **anion gap metabolic acidosis** due to the accumulation of formic acid. - The acidosis contributes significantly to the overall toxicity and clinical manifestations. *Blindness* - This statement is correct. **Blindness** is a classic and feared complication of methanol poisoning. - **Formic acid** specifically targets the **optic nerve** and retina, leading to **optic neuropathy** and permanent vision loss.

Q: Which of the following is likely to cause bull's-eye retinopathy?

Chloroquine. ***Chloroquine*** - **Chloroquine** and **hydroxychloroquine** are known to cause a dose-dependent retinopathy, often described as "**bull's-eye maculopathy**." - This toxicity manifests as pigmentary changes in the **macula**, leading to visual field defects, especially paracentral scotomas. *Isoniazid (INH)* - Isoniazid is primarily associated with **peripheral neuropathy** and **hepatotoxicity**. - It does not typically cause bull's-eye retinopathy. *Ethambutol* - Ethambutol is known to cause **optic neuritis** and **red-green color blindness** due to optic nerve damage. - While it affects vision, it does not lead to bull's-eye retinopathy. *Corticosteroids* - Long-term use of corticosteroids can lead to **posterior subcapsular cataracts** and **glaucoma**. - They are not associated with bull's-eye retinopathy.

Q: Which of the following drugs was classified as Category X (highest teratogenic risk) in the former FDA pregnancy risk classification system?

Isotretinoin. ***Isotretinoin*** - **Isotretinoin** is a powerful teratogen with **high risk of causing severe birth defects** including craniofacial, cardiac, thymic, and CNS malformations if taken during pregnancy. - Under the former FDA classification (discontinued 2015), it was Category X due to its significant teratogenic potential. - Requires strict contraception programs (iPLEDGE in US, pregnancy prevention programs globally) for all patients of childbearing potential. - **Absolute contraindication in pregnancy.** *Penicillin* - **Penicillin** was classified as Pregnancy Category B under the former system. - Generally considered **safe for use during pregnancy** when indicated for bacterial infections. - No evidence of teratogenic effects in human studies. - Widely used throughout pregnancy for appropriate indications. *Thiopental* - **Thiopental** was classified as Pregnancy Category C under the former system. - Used cautiously during pregnancy, typically only when **potential benefits outweigh risks**, primarily in situations requiring general anesthesia. - Short-term use for induction of anesthesia is generally considered acceptable when medically necessary. *Acetylsalicylic acid (Aspirin)* - **Aspirin** was Category C in first/second trimesters and Category D in third trimester under the former system. - **High doses and chronic use** carry risks including premature closure of **ductus arteriosus**, impaired platelet function, and increased bleeding risk. - Low-dose aspirin (75-150 mg) is now commonly used for prevention of preeclampsia in high-risk pregnancies. - Third trimester use of full doses should be avoided due to fetal and maternal bleeding complications.

Q: Which of the following statements about clinical trials is true?

Randomized controlled trial in patients is done in Phase 3. ***Randomized controlled trial in patients is done in Phase 3*** - **Phase 3 trials** involve large groups of patients to confirm the drug's effectiveness, monitor side effects, and compare it to standard treatments. - These trials are typically **randomized, controlled**, and often multicenter, providing robust data for regulatory approval. *Post-marketing surveillance is done in Phase 3* - **Post-marketing surveillance** (Phase 4) occurs after a drug has been approved and is available to the general public. - Its purpose is to monitor for long-term or rare side effects not detected in earlier, smaller trials. *Safety and non-toxicity is evaluated in Phase 2* - While safety is monitored in all phases, **Phase 1 trials** are primarily focused on assessing the **safety, dosage, and pharmacokinetics** of a new drug in a small group of healthy volunteers. - **Phase 2 trials** primarily evaluate the drug's **effectiveness** and further assess safety in a larger group of patients with the target disease. *Unit of study in Phase 1 is Patients* - The primary unit of study in **Phase 1 trials** is typically a small group of **healthy volunteers** (20-100 individuals) to determine the drug's safety, dosage, and pharmacokinetic profile. - Patients are included in later phases (Phase 2 and 3) once initial safety in healthy individuals has been established.

Q: Which of the following is a safe drug for a nursing mother?

Digoxin. ***Digoxin*** - **Digoxin** is considered generally safe during lactation because it has a **low milk-to-plasma ratio** and is poorly absorbed orally by the infant. - The amount of digoxin transferred into breast milk is minimal and unlikely to cause clinically significant effects in the infant. *Chloramphenicol* - **Chloramphenicol** can cause severe adverse effects in infants, including **bone marrow suppression** and the **gray baby syndrome**, due to its ability to cross into breast milk. - Its use is contraindicated in nursing mothers due to these serious risks. *Lithium* - **Lithium** is excreted into breast milk and can reach therapeutic levels in the infant, potentially causing **lethargy**, **hypotonia**, **cyanosis**, and **cardiovascular adverse effects**. - Monitoring infant serum lithium levels is crucial if used, but it's generally advised against due to safety concerns. *Amphetamines* - **Amphetamines** are secreted into breast milk and can cause **irritability**, **poor feeding**, **sleep disturbances**, and even **seizures** in nursing infants. - Due to the high risk of central nervous system stimulation and other adverse effects, amphetamines are generally considered contraindicated during breastfeeding.

Q: Which of the following is not an adverse effect of chronic amiodarone therapy?

Systemic lupus erythematosus. ***Systemic lupus erythematosus*** - Amiodarone is not typically associated with inducing or exacerbating **systemic lupus erythematosus** (SLE). - SLE is an **autoimmune disease** with a distinct set of symptoms and serological markers, rarely linked to amiodarone. *Pulmonary Fibrosis* - **Pulmonary fibrosis** is a well-known, potentially severe adverse effect of chronic amiodarone therapy, occurring due to drug accumulation in lung tissue. - Patients may present with **dyspnea, cough**, and diffuse interstitial infiltrates on chest imaging. *Hypothyroidism* - Amiodarone contains **iodine**, and its metabolites can inhibit thyroid hormone synthesis and release, leading to **hypothyroidism**. - This is a common endocrine side effect, often requiring **thyroid hormone replacement**. *Hyperthyroidism* - Amiodarone can also cause **hyperthyroidism** through two main mechanisms: an iodine-induced type (Type 1) or a destructive thyroiditis (Type 2). - Both types lead to excessive thyroid hormone levels and distinct clinical presentations.

Q: Pralidoxime is not useful in poisoning with which of the following?

Carbamate. ***Carbamate*** - Pralidoxime (2-PAM) is an **acetylcholinesterase reactivator** that works by detaching organophosphates from the active site of the enzyme. - Carbamates bind **reversibly** to acetylcholinesterase, and the enzyme-carbamate complex dissociates spontaneously within hours, making pralidoxime **unnecessary**. - Since the enzyme reactivates on its own, pralidoxime offers no therapeutic benefit in carbamate poisoning and is therefore **not indicated**. *Malathion* - Malathion is an **organophosphate insecticide** that inhibits acetylcholinesterase irreversibly. - Pralidoxime is effective in reactivating acetylcholinesterase inhibited by malathion, especially if administered early. *Parathion* - Parathion is an **organophosphate insecticide** that causes irreversible inhibition of acetylcholinesterase. - Pralidoxime is indicated for parathion poisoning to restore enzyme function and reverse cholinergic symptoms. *DFP* - DFP (Diisopropylfluorophosphate) is a potent **organophosphate nerve agent** that irreversibly inhibits acetylcholinesterase. - Pralidoxime is used in the treatment of DFP poisoning to reactivate the enzyme.

Q: Which of the following drugs can cause drug-induced systemic lupus erythematosus?

All of these. ***All of these*** - **Hydralazine**, **procainamide**, and **isoniazid (INH)** are all well-known medications identified to cause drug-induced systemic lupus erythematosus (DILE). - DILE typically presents with symptoms similar to idiopathic SLE, often including **arthralgia**, **myalgia**, and **serositis**, and usually resolves upon discontinuation of the culprit drug. *Hydralazine* - This **antihypertensive medication** is a common cause of DILE, particularly at higher doses and with prolonged use. - The mechanism is thought to involve its metabolism into reactive intermediates that can modify proteins and induce an **autoimmune response**. *Procainamide* - This **antiarrhythmic drug** is one of the most frequently implicated medications in causing DILE. - It often leads to the development of **anti-histone antibodies**, a hallmark of drug-induced lupus. *INH* - **Isoniazid**, an antibiotic used to treat **tuberculosis**, can also induce DILE. - Similar to other DILE-inducing drugs, INH's metabolic pathways are thought to contribute to the autoimmune process leading to lupus-like symptoms.

Q: Which of the following drugs is not associated with hepatotoxicity?

Streptomycin. ***Streptomycin*** - **Streptomycin** is an aminoglycoside antibiotic primarily associated with **ototoxicity** (vestibular and cochlear damage) and **nephrotoxicity**, but not commonly with significant hepatotoxicity [1]. - While all drugs can theoretically cause liver injury in susceptible individuals, streptomycin's established adverse effect profile does not highlight hepatotoxicity as a common or primary concern [1]. *Allopurinol* - **Allopurinol**, used to treat gout, can cause a range of adverse effects, including **hypersensitivity reactions** which may manifest with liver injury, such as **hepatitis** or **cholestasis**. - Severe cases can lead to allopurinol hypersensitivity syndrome, involving **rash**, **eosinophilia**, **fever**, and **hepatotoxicity**. *Sulfonamide* - **Sulfonamides** are a class of antibiotics known for various adverse effects, including **hypersensitivity reactions** that can lead to **drug-induced liver injury**. - They can cause different patterns of hepatotoxicity, including **cholestatic hepatitis**, **granulomatous hepatitis**, and even **fulminant hepatic failure** in rare cases. *Isoniazid* - **Isoniazid** (INH), a first-line anti-tuberculosis drug, is well-known for causing **drug-induced hepatotoxicity**, ranging from asymptomatic elevation of liver enzymes to **acute hepatitis** and **fulminant hepatic failure** [2]. - Risk factors include advanced age, concurrent use of rifampicin, alcohol consumption, and slow acetylator status [2]. - Regular monitoring of liver function tests is recommended during INH therapy [2].

Q: Which medication is the primary treatment for muscarinic effects in acute organophosphate poisoning?

Atropine. ***Atropine*** - **Atropine** is a **muscarinic receptor antagonist** that directly blocks the effects of excessive acetylcholine at muscarinic sites, thereby reversing symptoms like bradycardia, bronchospasm, and excessive secretions seen in organophosphate poisoning. - It is the **primary agent** used to manage the muscarinic symptoms and is titrated until bronchorrhea and bronchospasm resolve. *Neostigmine* - **Neostigmine** is an **acetylcholinesterase inhibitor**, which would worsen the condition by increasing acetylcholine levels further. - It is used in conditions like **myasthenia gravis** to improve muscle strength, not in organophosphate poisoning. *Tubocurarine* - **Tubocurarine** is a **nicotinic receptor antagonist**, specifically a competitive neuromuscular blocker. - While organophosphate poisoning can affect nicotinic receptors, tubocurarine is not the primary treatment for muscarinic effects and could worsen respiratory depression in this context. *Pralidoxime* - **Pralidoxime** (2-PAM) is an **acetylcholinesterase reactivator** that can regenerate the enzyme, thereby reversing both muscarinic and nicotinic effects. - While crucial for reversing nicotinic effects and preventing 'aging' of the enzyme, it is **not the primary treatment for acute muscarinic crisis**; atropine is.

Question 1

Which of the following statements about methyl alcohol poisoning is incorrect?

Accepted Answer

Fomepizole competitively inhibits aldehyde dehydrogenase

Answer

Effects are due to formic acid

Answer

Metabolic acidosis

Answer

Blindness

Question 2

Which of the following is likely to cause bull's-eye retinopathy?

Accepted Answer

Chloroquine

Answer

Isoniazid (INH)

Answer

Ethambutol

Answer

Corticosteroids

Question 3

Which of the following drugs was classified as Category X (highest teratogenic risk) in the former FDA pregnancy risk classification system?

Accepted Answer

Isotretinoin

Answer

Penicillin

Answer

Thiopental

Answer

Acetylsalicylic acid

Question 4

Which of the following statements about clinical trials is true?

Accepted Answer

Randomized controlled trial in patients is done in Phase 3

Answer

Post-marketing surveillance is done in Phase 3

Answer

Safety and non-toxicity is evaluated in Phase 2

Answer

Unit of study in Phase 1 is Patients

Question 5

Which of the following is a safe drug for a nursing mother?

Accepted Answer

Digoxin

Answer

Chloramphenicol

Answer

Lithium

Answer

Amphetamines

Question 6

Which of the following is not an adverse effect of chronic amiodarone therapy?

Accepted Answer

Systemic lupus erythematosus

Answer

Hypothyroidism

Answer

Pulmonary Fibrosis

Answer

Hyperthyroidism

Question 7

Pralidoxime is not useful in poisoning with which of the following?

Accepted Answer

Carbamate

Answer

Parathion

Answer

Malathion

Answer

DFP

Question 8

Which of the following drugs can cause drug-induced systemic lupus erythematosus?

Accepted Answer

All of these

Answer

Hydralazine

Answer

Procainamide

Answer

INH

Question 9

Which of the following drugs is not associated with hepatotoxicity?

Accepted Answer

Streptomycin

Answer

Allopurinol

Answer

Sulfonamide

Answer

Isoniazid

Question 10

Which medication is the primary treatment for muscarinic effects in acute organophosphate poisoning?

Accepted Answer

Atropine

Answer

Tubocurarine

Answer

Neostigmine

Answer

Pralidoxime

Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity — MCQs

On this page

Practice by Chapter

Want unlimited practice?